Close
We build the publications from HKU and external sources automatically. If you do not see your publications here, please note:
  • We receive data from HKU's Research Output System (ROS), after you or your people enter data there. If you have entered, or are going to enter data into ROS, we do not want to enter them manually into the Hub, as it will create duplicates. When entering data into ROS, please remember to include the DOI or ISBN. It will help us match on outside sources, and dedup.
  • If you are NOT going to enter publication data into ROS, or if you have publications from before your time at HKU, please put them into an EndNote file and send to us, hub@lib.hku.hk. It will allow us to enter in batch. HKU has a site license for EndNote. You may google for "endnote@hk". HKU Libraries can instruct on Endnote, either in class or one on one, http://lib.hku.hk/general/help.html
  • You may log into your ResearcherPage with your HKU Portal, and use the "Manage Publications" entry on the green left side menu, to unlink publications from your ResearcherPage, or, select a few to appear in a new box, "Selected Publications".
  • Confused? Please write to hub@lib.hku.hk.
HKU ResearcherPage: Ngan, HYS
 
rp00346.JPG picture
Professor Ngan, Hextan Yuen Sheung
顏婉嫦
Title
  • Head, Department of Obstetrics and Gynaecology
  • Tsao Yin Kai Professor in Obstetrics & Gynaecology
  • Professor, Chair of Obstetrics and Gynaecology
  • Tsao Yin-Kai Professorship in Obstetrics and Gynaecology
  • Clinical Professor
Dept:
Faculty:
Contact Information
rp00346.JPG picture
Tel:
  • 2255 4260
Office:
  •  
Professor Ngan, Hextan Yuen Sheung
顏婉嫦
Title
  • Head, Department of Obstetrics and Gynaecology
  • Tsao Yin Kai Professor in Obstetrics & Gynaecology
  • Professor, Chair of Obstetrics and Gynaecology
  • Tsao Yin-Kai Professorship in Obstetrics and Gynaecology
  • Clinical Professor
Dept:
Faculty:
Research Interests:
(click to check for cognate researchers)
My URLs:
Also Cited As:
  • Ngan, Yuen-sheung, Hextan
  • Ngan, YS
  • Ngan, HY
  • Ngan, H
  • Hextan
     Biography

    Prof. Hextan YS Ngan is a Chair Professor and the Head of Department of Obstetrics & Gynaecology, the University of Hong Kong. She is also the team leader of Oncology Division of this department. Her research interests include basic, clinical and translational cancer research in gynaecology oncology. Her basic research interests have focus on the characterization of putative oncogenes and tumor suppressor genes, as well as their associated signaling pathways involved in the pathogenesis of ovarian, endometrial and cervical carcinomas. Her research group was the first to identify p73alpha is involved in enhancement of the radiosensitive in cervical cancer cells through with the upregulation of p21. Importantly, her group has recently found that the breast cancer–associated gene 3 (BCA3) acts as a novel protein interacting partner of TAp73 and potentiates TAp73 in mediating γ-irradiation–induced apoptosis. These studies reveal the significance of p73 in the radiosensitivity of cervical cancer cells. Moreover, her group has recently reported an important oncogenic transcriptional factor, FOXM1, is frequently overexpressed in cervical and ovarian cancers, and is significantly correlated with the progression and aggressiveness of these cancers. The inhibitory targeting of FOXM1 by RNAi, specific inhibitor e.g. thiostrepton, or even AMPK activators such as metformin could remarkably abrogate the oncogenic capacities of these cancer cells. Ovarian cancer is a relatively poor survival rate disease because of chemoresistance and high rate in tumor recurrence. Hence, her group is particularly interested in the delineation of the underlying mechanisms associated with tumorigenesis and chemoresistance of this disease. Recent studies her group has not only identified the oncogenic role of FOXM1 in ovarian cancer, they also have found the signaling adaptors, GRB7 and its variant GRB7v, are aberrantly upregulated and associated with a variety of oncogenic capacities by modulating differential signaling pathways. These findings may shed the light of exploring potential therapeutic interventions through targeting these genes. Future studies will include the study of the impacts of tumor microenvironment and cancer cell metabolism on these key pathways involved in the aggressiveness and chemoresistance of ovarian cancer.

    Her clinical translational research effort have focused on cervical cancer screening especially on the role of HPV testing as well as on psychosocial studies including quality of life. In addition, the identification of new molecular markers in addition to routine HPV screening test is another area of her interested research. Currently her group is conducting a study to compare different HPV test. Lastly, her group has also taken part in contract clinical trials mainly in ovarian cancer treatment and HPV vaccines.

     
     Honours, Awards & Prizes
    Loading... 180 0 20 0 false
     Professional Societies
    Loading... 150 0 20 0 false

     ! 

    Close

    Please give us some feedback!